Securden, Inc., a leading provider of Privileged Access and Identity Security solutions, today announced that it has been recognized in the Gartner research report, "How to Manage Admin Privileges on ...
PE: How can teams reduce patient burden without weakening their science? Schwab: Number one is lean trial design. We should ...
A total of 91,403 sessions targeted public LLM endpoints to find leaks in organizations' use of AI and map an expanding ...
Managing security across 1000+ endpoints is no longer a scale problem alone; it is a complexity problem. Modern enterprise ...
Security researchers with GreyNoise say they've detected a campaign in which the threat actors are targeting more than 70 popular AI LLM models in a likely reconnaissance mission that will feed into ...
A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...
As 2026 begins, a subtle shift is underway in the air-cargo map of the Americas. The Caribbean, long treated as peripheral or ...
Threat actors are systematically hunting for misconfigured proxy servers that could provide access to commercial large ...
In the third part of her conversation with PharmExec, Trialynx founder and CEO Angela Schwab discusses the causes and ...
Two coordinated campaigns generated more than 91,000 attack sessions against AI infrastructure between October and January, ...
"MetaVia OXM analogue agonist meets endpoints in Phase Ib weight loss trial" was originally created and published by Clinical ...
Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback